BEIJING, May 11, 2026 /PRNewswire/ -- On April 30, Coremail officially unveiled its AI-Native Secure Email System at the 9th Digital China Summit, showcasing the company's continued innovation and technical expertise in enterprise email and intelligent workplace collaboration.
As AI enters the "Year of the Agent" in 2026, artificial intelligence is evolving into a new form of digital productivity capable of intelligent planning and cross-scenario coordination. At the same time, email is transforming from a traditional messaging tool into critical infrastructure that connects enterprise systems and business data flows. In response to this shift, Coremail has introduced its AI-Native Secure Email System built around a "Perceive-Think-Act" architecture.
AI-Native Email System for Smarter Workflows
The CLI-driven model is emerging as a key foundation for building agent-friendly systems, and the Coremail AI-Native Secure Email System is designed to fully unlock AI's operational value through this architecture. Powered by large language models as its cognitive engine, agents as its execution layer, and enterprise data as its operational core, the system is helping transform email workflows from manual operations into AI-assisted collaboration.
The system is designed to support six core enterprise scenarios, including email classification, scheduling, approval workflows, workplace collaboration, email analytics, and system operations. It enables capabilities such as advanced email retrieval, intelligent meeting coordination, automated analysis and classification, and AI-assisted operations management.
Powered by user-profile and behavioral analysis, the smart dashboard can automatically identify business priorities and task urgency, helping users cut through information overload. Through coordinated multi-agent collaboration, the system enables seamless information orchestration and operational automation across emails and business processes, further enhancing operational efficiency.
| Agent Capability | Core Functions |
| Email Classification Agent | Filters and prioritizes important emails |
| Email Search Agent | Supports advanced email retrieval and fast information discovery |
| Email Analysis Agent | Organizes communication context and assists in generating analytical reports |
| Meeting Scheduling Agent | Coordinates meeting arrangements and reduces repetitive communication |
| Email Operations Agent | Performs intelligent troubleshooting and diagnostics to ensure stable system operations |
Agent Capability
Core Functions
Email Classification Agent
Filters and prioritizes important emails
Email Search Agent
Supports advanced email retrieval and fast information discovery
Email Analysis Agent
Organizes communication context and assists in generating analytical reports
Meeting Scheduling Agent
Coordinates meeting arrangements and reduces repetitive communication
Email Operations Agent
Performs intelligent troubleshooting and diagnostics to ensure stable system operations
In terms of ecosystem integration, the system supports the Model Context Protocol (MCP), extending email beyond its traditional boundaries. Within a secure sandbox environment, third-party tools and APIs can be dynamically integrated on demand, enabling email to serve as a unified entry point for enterprise-wide workflow orchestration and transforming it from an information container into a business information hub.
"AI is reshaping enterprise productivity, and email is evolving from a communication tool into an intelligent collaboration hub. Coremail will continue advancing AI-native innovation to help enterprises build more secure and efficient digital workplaces," said Marvin Wu, Vice President of Coremail.
Deep Security Controls with Strict Permission Governance
The Coremail AI-Native Secure Email System is built around a deeply secure and controllable execution framework powered by intelligent agents. Based on the ReAct (Reasoning + Acting) framework, the system brings all tasks into a standardized lifecycle spanning perception, planning, execution, and feedback, helping ensure complex workflows operate within governed business boundaries.
The system adopts a dual-layer sandbox isolation architecture built around a user-level sandbox model and the principle of least-privilege access control. Under this framework, AI agents operate exclusively within independent encrypted execution environments, enabling automated orchestration across complex email workflows while maintaining strict control over data access and permission boundaries. In doing so, the system delivers both operational efficiency and enterprise-grade security protection.
In addition, the Coremail AI-Native Secure Email System introduces comprehensive upgrades across interface design and user experience. Features such as a three-pane information layout, optimized grouping logic, floating prompts, and quick-access functions help streamline operations and create a more intuitive workplace experience.
Driven by AI innovation and built with security at its core, the Coremail AI-Native Secure Email System is redefining the enterprise email experience for the intelligent workplace era. Looking ahead, Coremail will continue advancing AI-native innovation and delivering trusted products and services that help enterprises operate with greater efficiency, security, and resilience in the age of AI.
For more information, please visit: www.coremail.ai
About Coremail: Coremail is a leading enterprise email and collaboration solutions provider with over 27 years of innovation in secure communication technologies. Serving over 20,000 enterprise customers and supporting over 1 billion end users, Coremail is recognized for its stability, scalability, and AI-driven capabilities, with solutions widely adopted across government, finance, education, healthcare, and energy sectors.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Coremail Launches AI-Native Secure Email System for the Agent Era
|
Avalere Health Japan is designed with the full healthcare experience in mind, launching with an elite integrated team that brings together market access, medical, and marketing specialists, along with strategic consulting expertise.
TOKYO, May 11, 2026 /PRNewswire/ -- Avalere Health, a global strategic partner for the healthcare industry, today announces the launch of its Japan office. The move marks a significant expansion of Avalere Health's global footprint, and the launch of a new strategic offering is designed to support Japanese biopharmaceutical companies end-to-end across the product lifecycle.
"The Japanese domestic drug market is witnessing explosive growth driven by oncology drugs with high demand for diabetes, immunology, and rare disease areas. These are therapeutic areas where Avalere Health has deeply entrenched expertise. Opening an office in the region is a natural progression, but more than that, it contributes to our global promise, commitment, and ability to reach every patient possible," says Amar Urhekar, CEO.
Situated in the heart of Tokyo and led by IPG veteran Junji Yokokawa, Avalere Health Japan offers a unique proposition for biopharmaceutical clients. Unlike small agencies or large network offerings, Avalere Health Japan has been perfectly formed to provide integrated solutions to healthcare's greatest challenges from day one. They will be supported by Avalere Health's global leadership team's extensive experience of building networks and agencies in the Asia-Pacific region. Urhekar spent five years as President, Japan and EVP Asia Pacific with McCann Healthcare Worldwide, as well as a further five years of senior positions within the region.
Avalere Health Japan's nimble team unite healthcare marketing, market access, and medical expertise to address the complexities of healthcare product launches in Japan. Combining deep knowledge of the Japanese landscape with global best practices, its experts support biopharmaceutical clients to navigate complex regulatory, pricing, physician, and patient engagement challenges – accelerating access, demonstrating value, and achieving stronger, more sustainable success at launch and beyond.
"I'm incredibly excited to join Avalere Health – a deeply purposeful organization with a steadfast commitment to reaching every patient possible. Japan has one of the most advanced healthcare systems in the world, a fact I'm truly proud of. However, we face immense pressures, including a rapidly aging society, financial barriers for patients, and rural access gaps. We have brought together an incredible team thoughtfully structured for collaboration with the ideal mix of expertise for both driving commercial success and making a real difference for patients across the region," says Yokokawa.
"We have carefully selected leading experts with the right mix of skills to navigate the nuanced healthcare challenges of the region, creating a team positioned to drive real change across the healthcare continuum," adds Urhekar.
The organization's approach is grounded in scientific excellence, precise execution, and culturally attuned engagement with Japanese physicians and healthcare stakeholders. By combining rigorous compliance, high-quality medical communication, and tailored omnichannel engagement, Avalere Health helps its clients maximize value, mitigate risk, and build enduring impact.
About Avalere Health
United by one profound purpose: to reach EVERY PATIENT POSSIBLE. Avalere Health ensures every patient is identified, treated, supported, and cared for. Equally.
Its Advisory, Medical, and Marketing teams come together – powerfully and intentionally – to forge unconventional connections, building a future where healthcare is not a barrier and no patient is left behind.
Avalere Health is a global strategic partner, perfectly formed to solve the biggest challenges in health—at pace and at scale. United across the product lifecycle, the organization is uniquely positioned to understand every angle of life, health, and the human condition.
Visit www.avalerehealth.com and follow Avalere Health on LinkedIn.
Photo - https://mma.prnasia.com/media2/2975956/Avalere_Health_Junji_Yokokawa_and_Amar_Urhekar.jpg?p=medium600
Photo - https://mma.prnasia.com/media2/2975957/Avalere_Health_announces_expansion_to_Japan.jpg?p=medium600
Logo - https://mma.prnasia.com/media2/2088656/Avalere_Health_LogoV3_Color_Logo.jpg?p=medium600
Avalere Health Japan is designed with the full healthcare experience in mind, launching with an elite integrated team that brings together market access, medical, and marketing specialists, along with strategic consulting expertise.
TOKYO, May 11, 2026 /PRNewswire/ -- Avalere Health, a global strategic partner for the healthcare industry, today announces the launch of its Japan office. The move marks a significant expansion of Avalere Health's global footprint, and the launch of a new strategic offering is designed to support Japanese biopharmaceutical companies end-to-end across the product lifecycle.
"The Japanese domestic drug market is witnessing explosive growth driven by oncology drugs with high demand for diabetes, immunology, and rare disease areas. These are therapeutic areas where Avalere Health has deeply entrenched expertise. Opening an office in the region is a natural progression, but more than that, it contributes to our global promise, commitment, and ability to reach every patient possible," says Amar Urhekar, CEO.
Situated in the heart of Tokyo and led by IPG veteran Junji Yokokawa, Avalere Health Japan offers a unique proposition for biopharmaceutical clients. Unlike small agencies or large network offerings, Avalere Health Japan has been perfectly formed to provide integrated solutions to healthcare's greatest challenges from day one. They will be supported by Avalere Health's global leadership team's extensive experience of building networks and agencies in the Asia-Pacific region. Urhekar spent five years as President, Japan and EVP Asia Pacific with McCann Healthcare Worldwide, as well as a further five years of senior positions within the region.
Avalere Health Japan's nimble team unite healthcare marketing, market access, and medical expertise to address the complexities of healthcare product launches in Japan. Combining deep knowledge of the Japanese landscape with global best practices, its experts support biopharmaceutical clients to navigate complex regulatory, pricing, physician, and patient engagement challenges – accelerating access, demonstrating value, and achieving stronger, more sustainable success at launch and beyond.
"I'm incredibly excited to join Avalere Health – a deeply purposeful organization with a steadfast commitment to reaching every patient possible. Japan has one of the most advanced healthcare systems in the world, a fact I'm truly proud of. However, we face immense pressures, including a rapidly aging society, financial barriers for patients, and rural access gaps. We have brought together an incredible team thoughtfully structured for collaboration with the ideal mix of expertise for both driving commercial success and making a real difference for patients across the region," says Yokokawa.
"We have carefully selected leading experts with the right mix of skills to navigate the nuanced healthcare challenges of the region, creating a team positioned to drive real change across the healthcare continuum," adds Urhekar.
The organization's approach is grounded in scientific excellence, precise execution, and culturally attuned engagement with Japanese physicians and healthcare stakeholders. By combining rigorous compliance, high-quality medical communication, and tailored omnichannel engagement, Avalere Health helps its clients maximize value, mitigate risk, and build enduring impact.
About Avalere Health
United by one profound purpose: to reach EVERY PATIENT POSSIBLE. Avalere Health ensures every patient is identified, treated, supported, and cared for. Equally.
Its Advisory, Medical, and Marketing teams come together – powerfully and intentionally – to forge unconventional connections, building a future where healthcare is not a barrier and no patient is left behind.
Avalere Health is a global strategic partner, perfectly formed to solve the biggest challenges in health—at pace and at scale. United across the product lifecycle, the organization is uniquely positioned to understand every angle of life, health, and the human condition.
Visit www.avalerehealth.com and follow Avalere Health on LinkedIn.
Photo - https://mma.prnasia.com/media2/2975956/Avalere_Health_Junji_Yokokawa_and_Amar_Urhekar.jpg?p=medium600
Photo - https://mma.prnasia.com/media2/2975957/Avalere_Health_announces_expansion_to_Japan.jpg?p=medium600
Logo - https://mma.prnasia.com/media2/2088656/Avalere_Health_LogoV3_Color_Logo.jpg?p=medium600
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Avalere Health expands to Japan with a full-service Advisory, Medical, and Marketing offering, led by industry veteran Junji Yokokawa
Avalere Health expands to Japan with a full-service Advisory, Medical, and Marketing offering, led by industry veteran Junji Yokokawa
